The Global U.S. Compounding Pharmacies Market Growth Accelerated By Personalized Medicine Advancements
U.S. Compounding Pharmacies Market
Compounding pharmacies play a vital role in producing
personalized medicines which combines or alters pharmaceutical ingredients to
cater to the unique medical needs of patients. Their services include
customizing drug formulations in distinctive doses, delivery mechanisms and
combination of ingredients as per prescription for patients who cannot use
standard commercial drugs. This makes compounded medication more suitable,
effective and convenient.
The global U.S. Compounding Pharmacies Market is estimated
to be valued at US$ 5843.17 Bn in 2024
and is expected to exhibit a CAGR of
5.9% over the forecast period 2024 to 2031, as highlighted in a new report
published by Coherent Market Insights.
Market key trends:
The growth of the U.S. Compounding Pharmacies Market is primarily driven by the
advancements in personalized medicine approach. Personalized medicine tailors
medical treatment to an individual's specific disease characteristics,
genetics, and environment. The rising demand for customized drugs that
optimally suit an individual's medical needs has prompted significant
investments by players in this domain. Compounded drugs are preferred over
commercially available drugs in precision or personalized medicine as they
offer flexibility to pharmacists to develop formulations addressing unique response
of genes and lifestyle of each patient. This emerging trend is expected to
provide lucrative opportunities for participants in the U.S. Compounding
Pharmacies Market during the forecast period.
Segment Analysis
The U.S.
Compounding Pharmacies Market Analysis is dominated by 503B outsourcing
facilities segment. This is because 503B facilities focus on producing large
volumes of sterile compounds for hospitals and clinics. They are registered
with FDA and undergo stringent quality control and current good manufacturing
practice standards. These facilities play a crucial role is meeting the
increasing demand of compounded medications from healthcare institutions.
Key Takeaways
The global U.S. compounding pharmacies market is expected to witness high
growth. The global U.S. Compounding Pharmacies Market is estimated to be valued
at US$ 5843.17 Bn in 2024 and is expected to exhibit a CAGR of 5.9% over the
forecast period 2024 to 2031.
Regional
analysis -
California dominates the U.S. compounding pharmacies market due to presence of
large hospitals and clinics. It witnesses high demand for compounded medications
from these healthcare centers.
Key players related content comprises - Key players operating in the U.S.
compounding pharmacies market are Lionbridge, TransPerfect, SDL plc,
LanguageLine Solutions, Telelanguage, Straker Translations, GlobaLexicon, Day
Translations, GLOBO Language Solutions, Language Services Associates (LSA),
Language Connect, CSOFT International, WordExpress Corporation, The Geo Group
Corporation, Vocalink Global. These players are focusing on expanding their
503B outsourcing facilities to increase production of compounded sterile
preparations. They are also adopting automated compounding technologies to
ensure safety and accuracy.
Get more insights on this topic: https://www.ukwebwire.com/u-s-compounding-pharmacies-market-size-and-share-analysis-growth-trends-and-forecasts/
Explore
more information on this topic, Please visit: https://masstamilan.tv/understanding-non-small-cell-lung-cancer/
Comments
Post a Comment